GDK PHARMACY

Active

Private limited companyfounded 1988active for 38 yearsRomeinsesteenweg 450-452, 1853 Grimbergen, BelgiumKBO/BCE: BE 0434.953.344

From the official registers: KBO 38 annual accounts at the National Bank publications in the Belgian Official Gazette

Summary

GDK PHARMACY has been active since 1988 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €191,125 and a net result of €4,366. Equity has been stable since 2018 (±0.1% per year). Its solvency ranks better than 41% of 12,757 sector peers (NACE 47, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow Report Compare

GDK PHARMACYActiveChecked score 88/100

Risk analysis Report Compare

Official details

KBO

Status: Active since 03-08-1988 Normal situation
Legal form: Private limited company
Registered office: Romeinsesteenweg 450-452, 1853 Grimbergen
Activity: Retail sale of pharmaceutical products NACE 47730
Establishment unit: 2.040.035.407 1090 Jette, since 05-09-1988
Financial year end: 31 December
Peppol: Reachable since 26-11-2024

Company details

Board and ownership

Board

GDK FARMADirector · permanent representative Yves DE DECKER

Shareholders

GDK FARMA99.9%annual accounts 2025

Board & ownership

Financial position

88 Excellent Checked score 2025

Bankruptcy probabilitywithin 12 months: 0.2%

Annual accounts 2025

Gross margin: €273,711; ▲ 6.9%
Turnover: ≈ €1.0m; estimated
Profit: €4,366; ▼ 63.6%
Equity: €191,125; ▲ 5.9%
Total assets: €668,691; ▲ 12.2%
Staff: 3 FTE; ▲ 7.1%

2025 accounts filed 32 days before the deadline

Filed on 29-06-2026at the National Bank

Financials

Score breakdownraises riskSector: Retail trade (NACE 47)lowers riskFounded in 1988Liquidity: current ratio 1.25, cash €85,224Size: 3 FTE, total assets €668,691Show the evidence

Checked score

Score 2025

88 / 100

Excellent

Probability in this band: under 0.55%

Financially stronger than 38% of micro companies in retail trade (NACE 47)

Every signal that counts is listed under Signals.

Financial strength · tick: 2024

Weak

Solvency 54-1

equity 28.6% of total assets

Liquidity 28+2

short-term debt 71.4% · cash 12.7%

Profitability 41-24

return on assets 0.7%

Bankruptcy probability within 12 months

0.2% Very low

0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.6% (40,270 companies, NACE 47, micro)

Last 24 months 11-2024: 0.7% 12-2024: 0.7%● unchanged vs 11-2024 01-2025: 0.7%● unchanged vs 12-2024 02-2025: 0.7%● unchanged vs 01-2025 03-2025: 0.7%● unchanged vs 02-2025 04-2025: 0.7%● unchanged vs 03-2025 05-2025: 0.7%● unchanged vs 04-2025 06-2025: 0.7%● unchanged vs 05-2025 07-2025: 0.9%▲ +0.2 percentage points vs 06-2025 08-2025: 1.4%▲ +0.5 percentage points vs 07-2025highest value 09-2025: 0.3%▼ -1.1 percentage points vs 08-2025 10-2025: 0.3%● unchanged vs 09-2025 11-2025: 0.3%● unchanged vs 10-2025 12-2025: 0.3%● unchanged vs 11-2025 01-2026: 0.3%● unchanged vs 12-2025 02-2026: 0.3%● unchanged vs 01-2026 03-2026: 0.3%● unchanged vs 02-2026 04-2026: 0.3%● unchanged vs 03-2026 05-2026: 0.3%● unchanged vs 04-2026 06-2026: 0.3%● unchanged vs 05-2026 07-2026: 0.3%● unchanged vs 06-2026 08-2026: 0.6%▲ +0.3 percentage points vs 07-2026 09-2026: 0.7%▲ +0.1 percentage points vs 08-2026 10-2026: 0.2%▼ -0.5 percentage points vs 09-2026lowest value

Credit of up to €16,000 on 30-day terms is acceptable

Liquidity is tight, with a current ratio of 1.25 (1.26 in 2024), below the usual 1.5. Short-term debt is 71.4% and cash 12.7% of total assets. 71.4% of the assets are financed with debt and provisions.

Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100	Excellent	under 0.55%
60-74	Healthy	0.55% to 1.5%
45-59	Fair	1.5% to 4.2%
25-44	Weak	4.2% to 15.0%
0-24	Critical	over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 47, micro). It does better than 44% of them on solvency, 25% on liquidity, 31% on profitability and 53% on growth.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.

lowers riskraises riskneutral

Founded in 1988

Companies that have existed this long fail less often. How much that weighs depends on the rest of the company's profile.

KBO

Sector: Retail trade (NACE 47)

KBO

Liquidity: current ratio 1.25, cash €85,224

NBB · annual accounts

Size: 3 FTE, total assets €668,691

Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.

NBB · annual accounts

Growing equity

Reported equity is higher than in 2023 and did not fall compared with 2024. These amounts do not establish the cause of the change.

NBB · annual accounts 2025

Equity per financial year

1819202122232425

2018 to 2025 · latest year €191,125

Latest accounts filed on time

The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.

NBB · 10 filings

Deviation from the deadline

2025

32 days early

2024

29 days late

2023

30 days late

2022

74 days late

2021

31 days late

2020

31 days late

2019

38 days late

← before the deadline after the deadline →

tick = median of all Belgian filingsring = median in the sector

The company filed its last 7 accounts on average 29 days after the deadline. In the sector (NACE 47), the median for financial year 2024 was on the deadline day, and 47% of those companies filed late.

Searched, nothing found (2)

Next filing not due yet

The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 31 August (4 of the last 5 filed years within 43 days of that day).

Companies Code · seven months

Where today falls in the filing period

01-11-2026 today31-12-2026 year end31-07-2027 deadline

No strike-offs in the KBO publications

That holds for every publication since 2021.

KBO publications

Documents

Key facts about GDK PHARMACY

What is the company number of GDK PHARMACY?: The company number of GDK PHARMACY is 0434.953.344. The VAT number is the same number with BE in front: BE 0434.953.344.
Where is GDK PHARMACY based?: The registered office is at Romeinsesteenweg 450-452, 1853 Grimbergen.Company details
What does GDK PHARMACY do?: According to the KBO register, the main activity is retail sale of pharmaceutical products (NACE 47730).
What is the legal form of GDK PHARMACY?: The legal form of GDK PHARMACY is Private limited company (BV).
When was GDK PHARMACY founded?: GDK PHARMACY was founded on 03-08-1988.
Is GDK PHARMACY still active?: Yes, GDK PHARMACY is an active enterprise in the KBO register.
How many employees does GDK PHARMACY have?: GDK PHARMACY had an average of 3 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of GDK PHARMACY?: The turnover in financial year 2025 is ≈ €1.0m. This figure is estimated from the gross margin of €273,711 and 47 comparable companies (NACE 477). It probably lies between €770,000 and €1.6m.
Is GDK PHARMACY profitable?: In financial year 2025, GDK PHARMACY made a profit of €4,366.
Where can I find the annual accounts of GDK PHARMACY?: GDK PHARMACY filed 38 annual accounts with the National Bank of Belgium, the latest for financial year 2025.Annual accounts at the National Bank
When are the next annual accounts of GDK PHARMACY due?: GDK PHARMACY must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Companies linked to GDK PHARMACY

Parent and group

GDK FARMA99.9%

Comparable companies

These companies have the same main activity as GDK PHARMACY: retail sale of pharmaceutical products (NACE 47730). They are comparable in size and age: total assets between €593,000 and €732,000, founded between 1982 and 1991.

Company	Total assets	Gross margin
GDK PHARMACY Grimbergen	€668,691	€273,711
APOTHEEK DEBREMAEKER Halle	€661,199	€337,494
FALIPHARMA Sambreville	€731,975	€269,699
Pharmacie du Condroz Ciney	€669,587	€241,017
PHARMACIE BALDINI Charleroi	€592,904	€260,332
Pharmacie CANIVET Soignies	€664,707	€329,744
APOTEEK GINDERBUITEN Mol	€692,197	€304,987